Contrast Media Injectors Market

7500+ companies worldwide approach us every year for their revenue growth initiatives
Global top 2000 strategist rely on us for their growth strategies.
80% of fortune 2000 companies rely on our research to identify new revenue sources.
30000 High Growth Opportunities
95% renewal rate
KNOW MORE
  1. HOME
  2. Top Market Reports
  3. Contrast Media Injectors Market

Contrast Media Injectors Market Size, Share & Trends by Product (System (CT, MRI, Angiography, Mammo), Consumable, Accessories), Type (Single & Dual-head, Syringeless), Application (General Imaging, Interventional), End User (Hospital, Clinic), & Region - Global Forecast to 2029

FREE BROCHURE FREE SAMPLE REPORT
Report Code: MD 5244 Jul, 2024, by marketsandmarkets.com

Contrast Media Injectors Market Size, Share & Trends

The size of global contrast media injectors market in terms of revenue was estimated to be worth $1.6 billion in 2024 and is poised to reach $2.3 billion by 2029, growing at a CAGR of 8.0% from 2024 to 2029. The comprehensive research encompasses an exhaustive examination of industry trends, meticulous pricing analysis, patent scrutiny, insights derived from conferences and webinars, identification of key stakeholders, and a nuanced understanding of market purchasing dynamics.

A major driver is the rising incidence of cancer and cardiovascular diseases (CVDs), particularly among the aging population. Additionally, advancements in injector technology have led to the increasing demand for contrast media injectors catering diagnostic accuracy and early detection. Moreover, rising disposable incomes, coupled with expanding access to healthcare services in emerging markets, further fuel the demand contrast media injectors.

Contrast Media Injectors Market Trends

Contrast Media Injectors Market

To know about the assumptions considered for the study, Request for Free Sample Report

Contrast Media Injectors Market

e- Estimated; p- Projected

Contrast Media Injectors Market Dynamics

Driver: Rising volume of contrast-mediated CT and MRI examinations

Growing awareness among patients about the advantages of early disease diagnosis is a major factor driving the global demand for diagnostic imaging procedures. Clinicians worldwide prefer computed tomography (CT) and magnetic resonance imaging (MRI) as their primary imaging modalities. Complex imaging procedures require contrast media to obtain an improved visualization. Increasing use of contrast agents in the diagnostic procedures correlates with a rising demand for contrast media injection systems. Thus, growing target disease population coupled with promising outcomes associated with these scans are further expected to increase demand for contrast-enhanced procedures. This, in turn, will drive the demand for contrast injectors, further supporting the market growth.

Restraint: High cost of contrast media injector

High cost of contrast media injectors is one of the restrains in market. Premium product pricing hinders the adoption in emerging countries. Small healthcare facilities rely on third-party payers to reimburse the costs. The high cost of the equipment makes it difficult for most hospitals in emerging economies to afford this technology. Hence, smaller end users are hesitant to invest in this equipment. As a result, they often choose more economical conventional systems. This will hinder the adoption for transitioning from traditional systems to new technologically advanced systems, presenting a significant obstacle to the market.

Opportunity: Rising healthcare expenditure across emerging economies

Growing healthcare expenditure in emerging nations such as China, India, Brazil, and Mexico are expected to offer lucrative opportunities for contrast media injectors market. For instance, according to GLOBOCAN 2020 data, over 50% of the global cancer population resides in emerging economies. Increasing government initiatives towards providing advanced healthcare services and improving reimbursement coverage support the adoption of contrast media injectors. Rapid increase in the per-capita healthcare expenditure and the rising public demand for affordable healthcare in emerging economies to further expected to drive the demand for contrast media injectors in developing countries.

Challenges: Dearth of trained professionals

Handling advanced and sophisticated medical devices requires a high degree of technical skill and expertise. As per the Association of American Medical Colleges’ seventh annual analysis of physician supply and demand, the scarcity of radiologists and other specialists could potentially exceed 35,000 by 2034. Radiology technicians may witness employment growth of about 6% between 2022 and 2032 (Source: US Bureau of Labor Statistics). Although this is significant, the dearth of specialists and radiologists will challenge market growth.

Contrast Media Injectors Market Ecosystem

Contrast Media Injectors Market Ecosystem

By Product, the consumables segment accounted for the largest share of the contrast media injectors industry in 2022.

Based on product, the contrast media injectors market is segmented into contrast media injector systems, consumables, and accessories. In 2023, the consumables segment accounted for the largest market share. Rising awareness of proactive health and expansion of market players fuel the growth of market. Collaborations between market players is also supporting the growth of this segment. For instance, In November 2023, Bracco Imaging S.p.A. (Italy) collaborated with Ulrich GmbH CO KG (Germany) to market their MR injector system in the US.

By type, the dual-head segment accounted for the largest share of the contrast media injectors industry in 2022.

Based on type, the contrast media injectors market is segmented into dual-head injectors, single-head injectors, and syringeless injectors. In 2023, the dual-head segment accounted for the largest market share. Rising awareness related to early detection of chronic conditions and collaborations between key players in the market are expected to fuel the growth of this segment. Contrast agents are widely used for cancer patients. Increasing number of campaigns educating people about importance of early detection and rising reimbursements drives the adoption of technological advanced equipment driving the segment growth.

The radiology segment for application segment held the largest share of the contrast media injectors industry in 2023.

Based on application, the contrast media injectors market is segmented into radiology, interventional radiology, interventional cardiology. Radiology segment held largest share of the market in 2023 and is also expected to register a significant growth rate from 2024 to 2029. Use of AI tools in imaging and geographic expansion by the key players are driving the adoption. AI tools assists with accurate detection of the disease condition. Improved accuracy plays a crucial role in reducing misdiagnosis and improves patient outcomes.

By end user, the hospitals centers segment held the largest share of the contrast media injectors industry.

The contrast media injectors market is segmented by end users into hospitals and diagnostic imaging centers. However, the diagnostic imaging centers segment is expected to grow at the highest CAGR during the forecast period. The rise in number of chronic diseases, including cancer, increasing scanning procedures in the hospitals globally, and the potential of benefits of injectors observed in patients have contributed to the growth of this segment.

By region, North America is expected to be the largest market of the contrast media injectors industry by 2029.

The US and Canada accounted for a significant market share in 2023. North America's faster growth in the contrast media injectors market can be attributed to its technological leadership, robust healthcare infrastructure, favorable insurance coverage, growing funding and grants for developing advanced medical equipment, favorable regulatory scenario, strategic research collaboration, and a supportive market environment fostering innovation.

Contrast Media Injectors Market by Region

To know about the assumptions considered for the study, download the pdf brochure

As of 2023, prominent players in the market are Bayer AG (Germany), Bracco Imaging S.p.A. (Italy), Guerbet (France), MEDTRON AG (Germay), Ulrich GmbH & CO. KG (Germany), and Nemoto Kyorindo Co., Ltd. (Japan).

Scope of the Contrast Media Injectors Industry

Report Metric

Details

Market Revenue in 2024

$1.6 billion

Projected Revenue by 2029

$2.3 billion

Revenue Rate

Poised to Grow at a CAGR of 8.0%

Market Driver

Rising volume of contrast-mediated CT and MRI examinations

Market Opportunity

Rising healthcare expenditure across emerging economies

This report has segmented the global contrast media injectors market to forecast revenue and analyze trends in each of the following submarkets:

By Product
  • Injector Systems
  • Consumables
  • Accessories
By Application
  • Dual-head Injectors
  • Single-head Injectors
  • Syringeless Injectors
By Application
  • Radiology
  • Interventional Radiology
  • Interventional Cardiology
By End User
  • Hospitals
  • Diagnostic Imaging centers
By Region
  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America

Recent Developments of Contrast Media Injectors Industry:

  • In April 2024, Bayer AG (Germany) and Google Cloud (US) collaborated for the development of novel artificial intelligence (AI) solutions.
  • In November 2023, Bracco (Italy) and Ulrich GmbH (Germany) announced a partnership. This agreement will bring Bracco’s MR injector to the US under private label arrangement.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS
 
1 INTRODUCTION (Page No. - 29)
    1.1 STUDY OBJECTIVES 
    1.2 MARKET DEFINITION 
           1.2.1 INCLUSIONS & EXCLUSIONS
    1.3 MARKET SCOPE 
           1.3.1 MARKETS COVERED
           1.3.2 YEARS CONSIDERED
           1.3.3 CURRENCY CONSIDERED
    1.4 STAKEHOLDERS 
    1.5 SUMMARY OF CHANGES 
    1.6 RECESSION IMPACT 
 
2 RESEARCH METHODOLOGY (Page No. - 33)
    2.1 RESEARCH DATA 
          FIGURE 1 RESEARCH DESIGN
           2.1.1 SECONDARY RESEARCH
           2.1.2 PRIMARY RESEARCH
                    2.1.2.1 Primary sources
                    2.1.2.2 Key industry insights
                    2.1.2.3 Breakdown of primaries
                                FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
                                FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
    2.2 MARKET SIZE ESTIMATION 
          FIGURE 4 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
           2.2.1 BOTTOM-UP APPROACH
                    2.2.1.1 Approach 1: Company revenue estimation approach
                                FIGURE 5 CONTRAST MEDIA INJECTORS MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ESTIMATION)
                    2.2.1.2 Approach 2: Customer-based market estimation
                                FIGURE 6 CONTRAST MEDIA INJECTORS INDUSTRY SIZE ESTIMATION: BOTTOM-UP APPROACH
                    2.2.1.3 Growth forecast
                    2.2.1.4 CAGR projections
                                FIGURE 7 CAGR PROJECTION: SUPPLY-SIDE ANALYSIS
    2.3 DATA TRIANGULATION METHODOLOGY 
          FIGURE 8 DATA TRIANGULATION METHODOLOGY
    2.4 RESEARCH LIMITATIONS 
    2.5 MARKET SHARE ASSESSMENT 
           2.5.1 STUDY ASSUMPTIONS
           2.5.2 GROWTH RATE ASSUMPTIONS
    2.6 RISK ASSESSMENT 
          TABLE 1 RISK ASSESSMENT ANALYSIS
    2.7 RECESSION IMPACT ANALYSIS 
 
3 EXECUTIVE SUMMARY (Page No. - 44)
    FIGURE 9 CONTRAST MEDIA INJECTORS MARKET, PRODUCT,  2024 VS. 2029 (USD MILLION)
    FIGURE 10 CONTRAST MEDIA INJECTORS INDUSTRY, BY TYPE, 2024 VS. 2029 (USD MILLION)
    FIGURE 11 MARKET, BY APPLICATION,  2024 VS. 2029 (USD MILLION)
    FIGURE 12 MARKET, BY END USER,  2024 VS. 2029 (USD MILLION)
    FIGURE 13 GEOGRAPHIC SNAPSHOT OF MARKET
 
4 PREMIUM INSIGHTS (Page No. - 48)
    4.1 CONTRAST MEDIA INJECTORS MARKET OVERVIEW 
          FIGURE 14 GROWING ADOPTION OF CONTRAST-MEDIATED CT AND MRI DIAGNOSTIC PROCEDURES TO DRIVE MARKET
    4.2 NORTH AMERICA: CONTRAST MEDIA INJECTORS INDUSTRY,  BY PRODUCT AND COUNTRY (2023) 
          FIGURE 15 CONSUMABLES SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN US (2023)
    4.3 MARKET, BY APPLICATION,  2024 VS. 2029 (USD MILLION) 
          FIGURE 16 INTERVENTIONAL CARDIOLOGY SEGMENT TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
    4.4 MARKET, BY END USER,  2024 VS. 2029 (USD MILLION) 
          FIGURE 17 DIAGNOSTIC IMAGING CENTERS SEGMENT TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
    4.5 MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 
          FIGURE 18 EMERGING MARKETS PROJECTED TO REACH HIGHER GROWTH RATES DURING FORECAST PERIOD
 
5 MARKET OVERVIEW (Page No. - 51)
    5.1 INTRODUCTION 
    5.2 MARKET DYNAMICS 
          FIGURE 19 CONTRAST MEDIA INJECTORS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
           5.2.1 DRIVERS
                    5.2.1.1 Rising incidence of cancer and cardiovascular diseases
                                FIGURE 20 NEWLY DIAGNOSED CANCER CASES (MILLION)
                                TABLE 2 PROJECTED INCREASE IN GLOBAL NUMBER OF CANCER PATIENTS,  2020 VS. 2030 VS. 2040
                    5.2.1.2 Increasing volume of contrast-mediated MRI and CT procedures
                                TABLE 3 NUMBER OF MRI EXAMS PERFORMED PER 1,000 INHABITANTS, BY COUNTRY, 2019−2021
                                TABLE 4 NUMBER OF CT EXAMS PERFORMED PER 1,000 INHABITANTS, BY COUNTRY, 2019−2021
                    5.2.1.3 Growing approvals for CT and MRI contrast media to fuel demand for injectors
                    5.2.1.4 Favorable reimbursements in developed markets
           5.2.2 RESTRAINTS
                    5.2.2.1 High cost of contrast media injectors
           5.2.3 OPPORTUNITIES
                    5.2.3.1 High growth potential of emerging economies
                    5.2.3.2 Growing focus on mammography and nuclear imaging injectors
                    5.2.3.3 IT-enabled injector solutions
           5.2.4 CHALLENGES
                    5.2.4.1 Shortage of skilled professionals and limited technical expertise
    5.3 VALUE CHAIN ANALYSIS 
           5.3.1 RESEARCH & DEVELOPMENT
           5.3.2 MANUFACTURING & ASSEMBLY
           5.3.3 DISTRIBUTION, MARKETING & SALES, AND POST-SALES SERVICES
                    FIGURE 21 CONTRAST MEDIA INJECTORS INDUSTRY: VALUE CHAIN ANALYSIS
    5.4 SUPPLY CHAIN ANALYSIS 
           5.4.1 PROMINENT COMPANIES
           5.4.2 SMALL AND MEDIUM-SIZED ENTERPRISES
           5.4.3 END USERS
                    FIGURE 22 MARKET: SUPPLY CHAIN ANALYSIS
    5.5 ECOSYSTEM ANALYSIS 
          FIGURE 23 PARENT MARKET: ECOSYSTEM ANALYSIS
          TABLE 5 MARKET: ROLE IN ECOSYSTEM
    5.6 REGULATORY ANALYSIS 
          TABLE 6 REGULATORY APPROVALS REQUIRED FOR CONTRAST MEDIA INJECTORS, BY COUNTRY
           5.6.1 REGULATORY BODIES AND GOVERNMENT AGENCIES
                    5.6.1.1 North America: Regulatory bodies and government agencies
                                TABLE 7 NORTH AMERICA: LIST OF REGULATORY BODIES AND GOVERNMENT AGENCIES
                    5.6.1.2 Europe: Regulatory bodies and government agencies
                                TABLE 8 EUROPE: LIST OF REGULATORY BODIES AND GOVERNMENT AGENCIES
                    5.6.1.3 Asia Pacific: Regulatory bodies and government agencies
                                TABLE 9 ASIA PACIFIC: LIST OF REGULATORY BODIES AND GOVERNMENT AGENCIES
                    5.6.1.4 Latin America: Regulatory bodies and government agencies
                                TABLE 10 LATIN AMERICA: LIST OF REGULATORY BODIES AND GOVERNMENT AGENCIES
                    5.6.1.5 Middle East & Africa: Regulatory bodies and government agencies
                                TABLE 11 MIDDLE EAST & AFRICA: LIST OF REGULATORY BODIES AND GOVERNMENT AGENCIES
           5.6.2 REGULATORY GUIDELINES
                    5.6.2.1 US
                                TABLE 12 US FDA: MEDICAL DEVICE CLASSIFICATION
                                TABLE 13 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
                                FIGURE 24 PREMARKET NOTIFICATION: 510(K) APPROVALS FOR MEDICAL DEVICES
                    5.6.2.2 Canada
                                TABLE 14 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
                                FIGURE 25 CANADA: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES
                    5.6.2.3 Europe
                                FIGURE 26 EUROPE: CE APPROVAL PROCESS FOR MEDICAL DEVICES
                    5.6.2.4 Asia Pacific
                               5.6.2.4.1 Japan
                                              TABLE 15 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PHARMACEUTICAL AND MEDICAL DEVICE AGENCY (PMDA)
                               5.6.2.4.2 China
                                              TABLE 16 CHINA: CLASSIFICATION OF MEDICAL DEVICES
                               5.6.2.4.3 India
                               5.6.2.4.4 Brazil
    5.7 REIMBURSEMENT SCENARIO 
          TABLE 17 MEDICAL REIMBURSEMENT CODES FOR CONTRAST MEDIA IN US, 2023
    5.8 INVESTMENT & FUNDING SCENARIO 
          FIGURE 27 NUMBER OF DEALS & FUNDING INITIATIVES IN CONTRAST MEDIA INJECTORS MARKET, 2018−2022 (USD MILLION)
          FIGURE 28 NUMBER OF INVESTOR DEALS IN MARKET, BY KEY PLAYER, 2018–2022
          FIGURE 29 VALUE OF INVESTOR DEALS IN MARKET, BY KEY PLAYER, 2018–2022 (USD MILLION)
    5.9 PRICING ANALYSIS 
          FIGURE 30 AVERAGE SELLING PRICE TREND OF CONTRAST MEDIA INJECTORS,  BY PRODUCT
          FIGURE 31 AVERAGE SELLING PRICE TREND OF CONTRAST MEDIA INJECTORS, BY REGION
          TABLE 18 AVERAGE SELLING PRICE OF CONTRAST MEDIA INJECTORS, BY REGION
    5.10 TRADE ANALYSIS 
           TABLE 19 IMPORT DATA FOR CONTRAST MEDIA INJECTORS (HS CODE 9018), BY COUNTRY,  2019–2023 (USD THOUSAND)
           TABLE 20 EXPORT DATA FOR CONTRAST MEDIA INJECTORS (HS CODE 9018), BY COUNTRY,  2018–2022 (USD THOUSAND)
    5.11 PATENT ANALYSIS 
           FIGURE 32 PATENT ANALYSIS: MARKET (2013–2023)
    5.12 PORTER’S FIVE FORCE ANALYSIS 
           TABLE 21 PORTER’S FIVE FORCES ANALYSIS: MARKET
           5.12.1 THREAT OF NEW ENTRANTS
           5.12.2 THREAT OF SUBSTITUTES
           5.12.3 BARGAINING POWER OF SUPPLIERS
           5.12.4 BARGAINING POWER OF BUYERS
           5.12.5 INTENSITY OF COMPETITIVE RIVALRY
    5.13 KEY CONFERENCES & EVENTS IN 2024–2025 
           TABLE 22 LIST OF MAJOR CONFERENCES & EVENTS IN MARKET, 2024–2025
    5.14 CASE STUDY ANALYSIS 
           TABLE 23 CASE STUDY 1:  CARDIAC ENHANCEMENT ANALYSIS VIA CONTRAST MEDIA INJECTORS
    5.15 TECHNOLOGY ANALYSIS 
           5.15.1 KEY TECHNOLOGIES
                    5.15.1.1 MRI contrast media injectors
                    5.15.1.2 CT contrast media injectors
                    5.15.1.3 Angiography contrast media injectors
           5.15.2 COMPLEMENTARY TECHNOLOGIES
                    5.15.2.1 Diagnostic imaging modalities
           5.15.3 ADJACENT TECHNOLOGIES
                    5.15.3.1 Artificial intelligence with automated data systems
    5.16 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 
           FIGURE 33 REVENUE SHIFT IN CONTRAST MEDIA INJECTORS INDUSTRY
    5.17 KEY STAKEHOLDERS & BUYING CRITERIA 
           5.17.1 KEY STAKEHOLDERS IN BUYING PROCESS
                     FIGURE 34 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR PRIMARY FACTORS
                     TABLE 24 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS
                     FIGURE 35 BUYING CRITERIA FOR END USERS
                     TABLE 25 INFLUENCE OF END USERS ON BUYING PROCESS
                     FIGURE 36 INFLUENCE OF STAKEHOLDERS. BY END USER
                     TABLE 26 INFLUENCE OF STAKEHOLDERS, BY END USER
           5.17.2 BUYING CRITERIA
                     FIGURE 37 KEY BUYING CRITERIA FOR PROCESS CONTRAST MEDIA INJECTORS
                     TABLE 27 KEY BUYING CRITERIA FOR CONTRAST MEDIA INJECTORS
    5.18 UNMET NEEDS & KEY PAIN POINTS 
           TABLE 28 CONTRAST MEDIA INJECTORS MARKET: CURRENT UNMET NEEDS
    5.19 ARTIFICIAL INTELLIGENCE (AI) IN CONTRAST MEDIA INJECTORS INDUSTRY
 
6 CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT (Page No. - 94)
    6.1 INTRODUCTION 
          TABLE 29 CONTRAST MEDIA INJECTORS INDUSTRY, BY PRODUCT, 2022–2029 (USD MILLION)
    6.2 INJECTOR SYSTEMS 
          TABLE 30 CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 31 CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION)
           6.2.1 CT INJECTORS
                    6.2.1.1 Increasing number of CT scans to boost demand
                                TABLE 32 CT INJECTORS MARKET, BY REGION, 2022–2029 (USD MILLION)
           6.2.2 MRI INJECTORS
                    6.2.2.1 Rising funding initiatives for development of advanced systems to propel market
                                TABLE 33 MRI INJECTORS MARKET, BY REGION, 2022–2029 (USD MILLION)
           6.2.3 ANGIOGRAPHY INJECTORS
                    6.2.3.1 High uptake of cardiac catheterization procedures to drive market
                                TABLE 34 ANGIOGRAPHY INJECTORS MARKET, BY REGION, 2022–2029 (USD MILLION)
           6.2.4 OTHER INJECTORS
    6.3 CONSUMABLES 
          TABLE 35 CONTRAST MEDIA CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 36 CONTRAST MEDIA CONSUMABLES MARKET, BY REGION, 2022–2029 (USD MILLION)
           6.3.1 SYRINGES
                    6.3.1.1 Diverse size range to fuel uptake
                                TABLE 37 SYRINGES MARKET, BY REGION, 2022–2029 (USD MILLION)
           6.3.2 TUBES
                    6.3.2.1 Increasing demand for single-use products to drive market
                                TABLE 38 TUBES MARKET, BY REGION, 2022–2029 (USD MILLION)
           6.3.3 OTHER CONSUMABLES
                    TABLE 39 OTHER CONSUMABLES MARKET, BY REGION, 2022–2029 (USD MILLION)
    6.4 ACCESSORIES 
           6.4.1 ABILITY TO ENHANCE WORKFLOW EFFICIENCY TO SUPPORT MARKET GROWTH
                    TABLE 40 CONTRAST MEDIA ACCESSORIES MARKET, BY REGION, 2022–2029 (USD MILLION)
 
7 CONTRAST MEDIA INJECTORS MARKET, BY TYPE (Page No. - 102)
    7.1 INTRODUCTION 
          TABLE 41 MARKET, BY TYPE, 2022–2029 (USD MILLION)
    7.2 SINGLE-HEAD INJECTORS 
           7.2.1 COST-EFFICIENT AND USER-FRIENDLY DESIGN TO PROPEL MARKET
                    TABLE 42 CONTRAST MEDIA INJECTORS INDUSTRY FOR SINGLE-HEAD INJECTORS, BY REGION, 2022–2029 (USD MILLION)
    7.3 DUAL-HEAD INJECTORS 
           7.3.1 PRECISE CONTROL AND ENHANCED PATIENT SAFETY TO BOOST DEMAND
                    TABLE 43 MARKET FOR DUAL-HEAD INJECTORS, BY REGION, 2022–2029 (USD MILLION)
    7.4 SYRINGELESS INJECTORS 
           7.4.1 DIRECT ADMINISTRATION VIA TUBING TO SUPPORT MARKET GROWTH
                    TABLE 44 MARKET FOR SYRINGELESS INJECTORS, BY REGION, 2022–2029 (USD MILLION)
 
8 CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION (Page No. - 106)
    8.1 INTRODUCTION 
          TABLE 45 CONTRAST MEDIA INJECTORS INDUSTRY, BY APPLICATION, 2022–2029 (USD MILLION)
    8.2 RADIOLOGY 
           8.2.1 RISING NUMBER OF RADIOLOGY PROCEDURES TO DRIVE MARKET
                    TABLE 46 MARKET FOR RADIOLOGY, BY REGION,  2022–2029 (USD MILLION)
    8.3 INTERVENTIONAL CARDIOLOGY 
           8.3.1 RISING UPTAKE OF CORONARY CT ANGIOGRAMS TO PROPEL MARKET
                    TABLE 47 MARKET FOR INTERVENTIONAL CARDIOLOGY, BY REGION, 2022–2029 (USD MILLION)
    8.4 INTERVENTIONAL RADIOLOGY 
           8.4.1 INCREASING PREFERENCE FOR MINIMALLY INVASIVE PROCEDURES TO SUPPORT MARKET GROWTH
                    TABLE 48 MARKET FOR INTERVENTIONAL RADIOLOGY, BY REGION, 2022–2029 (USD MILLION)
 
9 CONTRAST MEDIA INJECTORS MARKET, BY END USER (Page No. - 110)
    9.1 INTRODUCTION 
          TABLE 49 CONTRAST MEDIA INJECTORS INDUSTRY, BY END USER, 2022–2029 (USD MILLION)
    9.2 HOSPITALS 
           9.2.1 HIGH PURCHASING POWER FOR ADVANCED EQUIPMENT TO SUPPORT MARKET GROWTH
                    TABLE 50 MARKET FOR HOSPITALS, BY REGION,  2022–2029 (USD MILLION)
    9.3 DIAGNOSTIC IMAGING CENTERS 
           9.3.1 INCREASING ESTABLISHMENT OF PRIVATE IMAGING CENTERS TO PROPEL MARKET
                    TABLE 51 MARKET FOR DIAGNOSTIC IMAGING CENTERS, BY REGION, 2022–2029 (USD MILLION)
 
10 CONTRAST MEDIA INJECTORS MARKET, BY REGION (Page No. - 113)
     10.1 INTRODUCTION 
             TABLE 52 CONTRAST MEDIA INJECTORS INDUSTRY, BY REGION, 2022–2029 (USD MILLION)
     10.2 NORTH AMERICA 
             FIGURE 38 NORTH AMERICA: CONTRAST MEDIA INJECTORS MARKET SNAPSHOT
             TABLE 53 NORTH AMERICA: MARKET, BY COUNTRY,  2022–2029 (USD MILLION)
             TABLE 54 NORTH AMERICA: MARKET, BY PRODUCT,  2022–2029 (USD MILLION)
             TABLE 55 NORTH AMERICA: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE,  2022–2029 (USD MILLION)
             TABLE 56 NORTH AMERICA: CONTRAST MEDIA INJECTORS CONSUMABLES MARKET, BY TYPE,  2022–2029 (USD MILLION)
             TABLE 57 NORTH AMERICA: MARKET, BY TYPE,  2022–2029 (USD MILLION)
             TABLE 58 NORTH AMERICA: MARKET, BY APPLICATION,  2022–2029 (USD MILLION)
             TABLE 59 NORTH AMERICA: CONTRAST MEDIA INJECTORS MARKET, BY END USER,  2022–2029 (USD MILLION)
             10.2.1 NORTH AMERICA: RECESSION IMPACT
             10.2.2 US
                        10.2.2.1 Rising adoption of technologically advanced products to drive market
                                      TABLE 60 US: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
                                      TABLE 61 US: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 62 US: CONTRAST MEDIA CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
             10.2.3 CANADA
                        10.2.3.1 Rising investments in medical imaging equipment to drive market
                                      TABLE 63 CANADA: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT,  2022–2029 (USD MILLION)
                                      TABLE 64 CANADA: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE,  2022–2029 (USD MILLION)
                                      TABLE 65 CANADA: CONTRAST MEDIA CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
     10.3 EUROPE 
             TABLE 66 EUROPE: CONTRAST MEDIA INJECTORS MARKET, BY COUNTRY,  2022–2029 (USD MILLION)
             TABLE 67 EUROPE: MARKET, BY PRODUCT,  2022–2029 (USD MILLION)
             TABLE 68 EUROPE: CONTRAST MEDIA INJECTORS SYSTEMS MARKET, BY TYPE,  2022–2029 (USD MILLION)
             TABLE 69 EUROPE: MARKET, BY TYPE,  2022–2029 (USD MILLION)
             TABLE 70 EUROPE: MARKET, BY APPLICATION,  2022–2029 (USD MILLION)
             TABLE 71 EUROPE: CONTRAST MEDIA INJECTORS MARKET, BY END USER,  2022–2029 (USD MILLION)
             10.3.1 EUROPE: RECESSION IMPACT
             10.3.2 GERMANY
                        10.3.2.1 Advancements in imaging technologies to fuel uptake
                                      TABLE 72 GERMANY: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT,  2022–2029 (USD MILLION)
                                      TABLE 73 GERMANY: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE,  2022–2029 (USD MILLION)
                                      TABLE 74 GERMANY: CONTRAST MEDIA CONSUMABLES MARKET, BY TYPE,  2022–2029 (USD MILLION)
             10.3.3 FRANCE
                        10.3.3.1 Increasing prevalence of cancer to propel market
                                      TABLE 75 FRANCE: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT,  2022–2029 (USD MILLION)
                                      TABLE 76 FRANCE: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE,  2022–2029 (USD MILLION)
                                      TABLE 77 FRANCE: CONTRAST MEDIA CONSUMABLES MARKET, BY TYPE,  2022–2029 (USD MILLION)
             10.3.4 UK
                        10.3.4.1 High incidence of CVD to propel market
                                      TABLE 78 UK: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
                                      TABLE 79 UK: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 80 UK: CONTRAST MEDIA CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
             10.3.5 ITALY
                        10.3.5.1 Rising incidence of chronic diseases to support market growth
                                      TABLE 81 ITALY: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
                                      TABLE 82 ITALY: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE,  2022–2029 (USD MILLION)
                                      TABLE 83 ITALY: CONTRAST MEDIA CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
             10.3.6 SPAIN
                        10.3.6.1 Shortage of skilled radiologists to restrain market
                                      TABLE 84 SPAIN: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
                                      TABLE 85 SPAIN: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE,  2022–2029 (USD MILLION)
                                      TABLE 86 SPAIN: CONTRAST MEDIA CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
             10.3.7 REST OF EUROPE
                        TABLE 87 REST OF EUROPE: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT,  2022–2029 (USD MILLION)
                        TABLE 88 REST OF EUROPE: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE,  2022–2029 (USD MILLION)
                        TABLE 89 REST OF EUROPE: CONTRAST MEDIA CONSUMABLES MARKET, BY TYPE,  2022–2029 (USD MILLION)
     10.4 ASIA PACIFIC 
             FIGURE 39 ASIA PACIFIC: CONTRAST MEDIA INJECTORS MARKET SNAPSHOT
             TABLE 90 ASIA PACIFIC: MARKET, BY COUNTRY,  2022–2029 (USD MILLION)
             TABLE 91 ASIA PACIFIC: MARKET, BY PRODUCT,  2022–2029 (USD MILLION)
             TABLE 92 ASIA PACIFIC: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE,  2022–2029 (USD MILLION)
             TABLE 93 ASIA PACIFIC: MARKET, BY TYPE,  2022–2029 (USD MILLION)
             TABLE 94 ASIA PACIFIC: MARKET, BY APPLICATION,  2022–2029 (USD MILLION)
             TABLE 95 ASIA PACIFIC: CONTRAST MEDIA INJECTORS MARKET, BY END USER,  2022–2029 (USD MILLION)
             10.4.1 ASIA PACIFIC: RECESSION IMPACT
             10.4.2 JAPAN
                        10.4.2.1 Rising geriatric population and subsequent increase in chronic diseases to drive market
                                      TABLE 96 JAPAN: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
                                      TABLE 97 JAPAN: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE,  2022–2029 (USD MILLION)
                                      TABLE 98 JAPAN: CONTRAST MEDIA CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
             10.4.3 CHINA
                        10.4.3.1 Rising incidence of cancer and increasing establishment of hospitals to boost demand
                                      TABLE 99 CHINA: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
                                      TABLE 100 CHINA: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE,  2022–2029 (USD MILLION)
                                      TABLE 101 CHINA: CONTRAST MEDIA CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
             10.4.4 INDIA
                        10.4.4.1 Growing investments in radiology to propel market
                                      TABLE 102 INDIA: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
                                      TABLE 103 INDIA: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE,  2022–2029 (USD MILLION)
                                      TABLE 104 INDIA: CONTRAST MEDIA CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
             10.4.5 AUSTRALIA
                        10.4.5.1 Increasing R&D investments for advanced diagnostic modalities to drive market
                                      TABLE 105 AUSTRALIA: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT,  2022–2029 (USD MILLION)
                                      TABLE 106 AUSTRALIA: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE,  2022–2029 (USD MILLION)
                                      TABLE 107 AUSTRALIA: CONTRAST MEDIA CONSUMABLES MARKET, BY TYPE,  2022–2029 (USD MILLION)
             10.4.6 SOUTH KOREA
                        10.4.6.1 Favorable reimbursements for diagnostic procedures to support market growth
                                      TABLE 108 SOUTH KOREA: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT,  2022–2029 (USD MILLION)
                                      TABLE 109 SOUTH KOREA: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE,  2022–2029 (USD MILLION)
                                      TABLE 110 SOUTH KOREA: CONTRAST MEDIA CONSUMABLES MARKET, BY TYPE,  2022–2029 (USD MILLION)
             10.4.7 REST OF ASIA PACIFIC
                        TABLE 111 REST OF ASIA PACIFIC: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
                        TABLE 112 REST OF ASIA PACIFIC: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 113 REST OF ASIA PACIFIC: CONTRAST MEDIA CONSUMABLES MARKET, BY TYPE,  2022–2029 (USD MILLION)
     10.5 LATIN AMERICA 
             TABLE 114 LATIN AMERICA: CONTRAST MEDIA INJECTORS MARKET, BY COUNTRY,  2022–2029 (USD MILLION)
             TABLE 115 LATIN AMERICA: MARKET, BY PRODUCT,  2022–2029 (USD MILLION)
             TABLE 116 LATIN AMERICA: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE,  2022–2029 (USD MILLION)
             TABLE 117 LATIN AMERICA: MARKET, BY TYPE,  2022–2029 (USD MILLION)
             TABLE 118 LATIN AMERICA: MARKET, BY APPLICATION,  2022–2029 (USD MILLION)
             TABLE 119 LATIN AMERICA: CONTRAST MEDIA INJECTORS MARKET, BY END USER,  2022–2029 (USD MILLION)
             10.5.1 LATIN AMERICA: RECESSION IMPACT
             10.5.2 BRAZIL
                        10.5.2.1 Growing awareness of early disease detection & diagnosis to drive market
                                      TABLE 120 BRAZIL: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT,  2022–2029 (USD MILLION)
                                      TABLE 121 BRAZIL: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE,  2022–2029 (USD MILLION)
                                      TABLE 122 BRAZIL: CONTRAST MEDIA CONSUMABLES MARKET, BY TYPE,  2022–2029 (USD MILLION)
             10.5.3 MEXICO
                        10.5.3.1 Inadequate healthcare infrastructure to restrain market
                                      TABLE 123 MEXICO: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT,  2022–2029 (USD MILLION)
                                      TABLE 124 MEXICO: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE,  2022–2029 (USD MILLION)
                                      TABLE 125 MEXICO: CONTRAST MEDIA CONSUMABLES MARKET, BY TYPE,  2022–2029 (USD MILLION)
             10.5.4 REST OF LATIN AMERICA
                        TABLE 126 REST OF LATIN AMERICA: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
                        TABLE 127 REST OF LATIN AMERICA: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 128 REST OF LATIN AMERICA: CONTRAST MEDIA CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
     10.6 MIDDLE EAST & AFRICA 
             10.6.1 IMPROVEMENTS IN HEALTHCARE INFRASTRUCTURE TO DRIVE MARKET
                        TABLE 129 MIDDLE EAST & AFRICA: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT,  2022–2029 (USD MILLION)
                        TABLE 130 MIDDLE EAST & AFRICA: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE,  2022–2029 (USD MILLION)
                        TABLE 131 MIDDLE EAST & AFRICA: MARKET, BY TYPE,  2022–2029 (USD MILLION)
                        TABLE 132 MIDDLE EAST & AFRICA: MARKET, BY APPLICATION,  2022–2029 (USD MILLION)
                        TABLE 133 MIDDLE EAST & AFRICA: CONTRAST MEDIA INJECTORS MARKET, BY END USER,  2022–2029 (USD MILLION)
             10.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT
 
11 COMPETITIVE LANDSCAPE (Page No. - 155)
     11.1 OVERVIEW 
     11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 
             11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN CONTRAST MEDIA INJECTORS MARKET
                        TABLE 134 OVERVIEW OF STRATEGIES DEPLOYED BY KEY MANUFACTURING COMPANIES
     11.3 REVENUE ANALYSIS 
             FIGURE 40 REVENUE SHARE ANALYSIS OF TOP PLAYERS IN CONTRAST MEDIA INJECTORS INDUSTRY (2019−2023)
     11.4 MARKET SHARE ANALYSIS 
             FIGURE 41 MARKET SHARE ANALYSIS OF KEY PLAYERS (2023)
             TABLE 135 CONTRAST MEDIA INJECTORS INDUSTRY: DEGREE OF COMPETITION
             11.4.1 RANKING OF KEY MARKET PLAYERS
                        FIGURE 42 RANKING OF KEY PLAYERS IN CONTRAST MEDIA INJECTORS INDUSTRY, 2023
     11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 
             11.5.1 STARS
             11.5.2 EMERGING LEADERS
             11.5.3 PERVASIVE PLAYERS
             11.5.4 PARTICIPANTS
                        FIGURE 43 CONTRAST MEDIA INJECTORS INDUSTRY: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
             11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
                        11.5.5.1 Company footprint
                                      FIGURE 44 CONTRAST MEDIA INJECTORS INDUSTRY: COMPANY FOOTPRINT
                        11.5.5.2 Product footprint
                                      TABLE 136 CONTRAST MEDIA INJECTORS INDUSTRY: PRODUCT FOOTPRINT
                        11.5.5.3 Application footprint
                                      TABLE 137 CONTRAST MEDIA INJECTORS INDUSTRY: APPLICATION FOOTPRINT
                        11.5.5.4 End-user footprint
                                      TABLE 138 CONTRAST MEDIA INJECTORS INDUSTRY: END-USER FOOTPRINT
                        11.5.5.5 Region footprint
                                      TABLE 139 CONTRAST MEDIA INJECTORS INDUSTRY: REGION FOOTPRINT
     11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023 
             11.6.1 PROGRESSIVE COMPANIES
             11.6.2 RESPONSIVE COMPANIES
             11.6.3 DYNAMIC COMPANIES
             11.6.4 STARTING BLOCKS
                        FIGURE 45 CONTRAST MEDIA INJECTORS INDUSTRY: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
             11.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
                        TABLE 140 MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS
                        TABLE 141 MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS
     11.7 COMPANY VALUATION & FINANCIAL METRICS 
             11.7.1 FINANCIAL METRICS
                        FIGURE 46 EV/EBITDA OF KEY VENDORS
             11.7.2 COMPANY VALUATION
                        FIGURE 47 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF  KEY VENDORS
     11.8 BRAND/PRODUCT COMPARISON 
             FIGURE 48 MARKET: BRAND/PRODUCT COMPARISON ANALYSIS
     11.9 COMPETITIVE SCENARIO 
             11.9.1 PRODUCT LAUNCHES & APPROVALS
                        TABLE 142 MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–MAY 2024
             11.9.2 DEALS
                        TABLE 143 MARKET: DEALS, JANUARY 2021–MAY 2024
             11.9.3 EXPANSIONS
                        TABLE 144 MARKET: EXPANSIONS, JANUARY 2021–MAY 2024
 
12 COMPANY PROFILES (Page No. - 171)
     12.1 KEY PLAYERS 
(Business overview, Products offered, Recent developments, MnM view, Key strengths, Strategic choices, and Weaknesses and Competitive threats)*
             12.1.1 BAYER AG
                        TABLE 145 BAYER AG: COMPANY OVERVIEW
                        FIGURE 49 BAYER AG: COMPANY SNAPSHOT (2023)
                        TABLE 146 BAYER AG: PRODUCTS OFFERED
                        TABLE 147 BAYER AG: DEALS, JANUARY 2021−MAY 2024
             12.1.2 BRACCO IMAGING S.P.A.
                        TABLE 148 BRACCO IMAGING S.P.A.: COMPANY OVERVIEW
                        TABLE 149 BRACCO IMAGING S.P.A.: PRODUCTS OFFERED
                        TABLE 150 BRACCO IMAGING S.P.A.: DEALS, JANUARY 2021−MAY 2024
                        TABLE 151 BRACCO IMAGING S.P.A.: EXPANSIONS, JANUARY 2021−MAY 2024
             12.1.3 GUERBET
                        TABLE 152 GUERBET: COMPANY OVERVIEW
                        FIGURE 50 GUERBET: COMPANY SNAPSHOT (2023)
                        TABLE 153 GUERBET: PRODUCTS OFFERED
                        TABLE 154 GUERBET: PRODUCT LAUNCHES, JANUARY 2021−MAY 2024
             12.1.4 ULRICH GMBH & CO. KG
                        TABLE 155 ULRICH GMBH & CO. KG: COMPANY OVERVIEW
                        TABLE 156 ULRICH GMBH & CO. KG: PRODUCTS OFFERED
                        TABLE 157 ULRICH GMBH & CO. KG: DEALS, JANUARY 2021−MAY 2024
             12.1.5 MEDTRON AG
                        TABLE 158 MEDTRON AG.: COMPANY OVERVIEW
                        TABLE 159 MEDTRON AG: PRODUCTS OFFERED
                        TABLE 160 MEDTRON AG: DEALS, JANUARY 2021−MAY 2024
             12.1.6 NEMOTO KYORINDO CO., LTD.
                        TABLE 161 NEMOTO KYORINDO CO., LTD.: COMPANY OVERVIEW
                        TABLE 162 NEMOTO KYORINDO CO., LTD.: PRODUCTS OFFERED
             12.1.7 SHENZHEN ANKE HIGH-TECH CO., LTD.
                        TABLE 163 SHENZHEN ANKE HIGH-TECH CO., LTD.: COMPANY OVERVIEW
                        TABLE 164 SHENZHEN ANKE HIGH-TECH CO., LTD.: PRODUCTS OFFERED
             12.1.8 SINO MDT
                        TABLE 165 SINO MDT: COMPANY OVERVIEW
                        TABLE 166 SINO MDT: PRODUCTS OFFERED
             12.1.9 APOLLO RT CO., LTD.
                        TABLE 167 APOLLO RT CO., LTD.: COMPANY OVERVIEW
                        TABLE 168 APOLLO RT CO., LTD.: PRODUCTS OFFERED
             12.1.10 SHENZHEN SEACROWN ELECTROMECHANICAL CO., LTD.
                        TABLE 169 SHENZHEN SEACROWN ELECTROMECHANICAL CO., LTD.: COMPANY OVERVIEW
                        TABLE 170 SHENZHEN SEACROWN ELECTROMECHANICAL CO., LTD.: PRODUCTS OFFERED
             12.1.11 SHENZHEN ANTMED CO., LTD.
                        TABLE 171 SHENZHEN ANTMED CO., LTD.: COMPANY OVERVIEW
                        TABLE 172 SHENZHEN ANTMED CO., LTD.: PRODUCTS OFFERED
             12.1.12 SHENZHEN LNKMED MEDICAL TECHNOLOGY CO., LTD.
                        TABLE 173 SHENZHEN LNKMED MEDICAL TECHNOLOGY CO., LTD.: COMPANY OVERVIEW
                        TABLE 174 SHENZHEN LNKMED MEDICAL TECHNOLOGY CO., LTD.: PRODUCTS OFFERED
             12.1.13 UNION MEDICAL SHENZHEN CO., LTD.
                        TABLE 175 UNION MEDICAL SHENZHEN CO., LTD.: COMPANY OVERVIEW
                        TABLE 176 UNION MEDICAL SHENZHEN CO., LTD.: PRODUCTS OFFERED
             12.1.14 SPECTRUM MEDICAL TECHNOLOGIES
                        TABLE 177 SPECTRUM MEDICAL TECHNOLOGIES: COMPANY OVERVIEW
                        TABLE 178 SPECTRUM MEDICAL TECHNOLOGIES: PRODUCTS OFFERED
             12.1.15 SHENZHEN BOON MEDICAL SUPPLY CO., LTD.
                        TABLE 179 SHENZHEN BOON MEDICAL SUPPLY CO., LTD.: COMPANY OVERVIEW
                        TABLE 180 SHENZHEN BOON MEDICAL SUPPLY CO., LTD.: PRODUCTS OFFERED
     12.2 OTHER PLAYERS 
             12.2.1 SCW MEDICATH LTD.: COMPANY OVERVIEW
             12.2.2 VYGON: COMPANY OVERVIEW
             12.2.3 NANJING FOINOE CO., LTD.: COMPANY OVERVIEW
             12.2.4 LEMER PAX: COMPANY OVERVIEW
             12.2.5 COMECER S.P.A.: COMPANY OVERVIEW
             12.2.6 TEMA SINERGIE S.P.A.: COMPANY OVERVIEW
             12.2.7 SHEEN MAN CO., LTD.: COMPANY OVERVIEW
             12.2.8 HONG KONG MEDI CO., LTD.: COMPANY OVERVIEW
             12.2.9 QINGDAO HIPROVE MEDICAL TECHNOLOGIES CO., LTD.: COMPANY OVERVIEW
             12.2.10 SHANGHAI KINDLY ENTERPRISE DEVELOPMENT GROUP CO., LTD: COMPANY OVERVIEW
 
*Details on Business overview, Products offered, Recent developments, MnM view, Key strengths, Strategic choices, and Weaknesses and Competitive threats might not be captured in case of unlisted companies.
 
13 APPENDIX (Page No. - 199)
     13.1 DISCUSSION GUIDE 
     13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’  SUBSCRIPTION PORTAL 
     13.3 CUSTOMIZATION OPTIONS 
     13.4 RELATED REPORTS 
     13.5 AUTHOR DETAILS 

The study involved four major activities in estimating the current size of the contrast media injectors market. Exhaustive secondary research was done to collect information on the market, peer, and parent markets. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation were used to estimate the market size of segments and subsegments.

Secondary Research

The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, company house documents, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial contrast media injectors market study. It was also used to obtain important information about the key players and market classification & segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

Primary Research

In the primary research process, various supply and demand sources were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and related key executives from various key companies and organizations in the contrast media injectors market. The primary sources from the demand side include hospitals, clinics, cancer care centers, and other end users. Primary research was conducted to validate the market segmentation, identify key players, and gather insights on key industry trends & key market dynamics.

A breakdown of the primary respondents is provided below:

Contrast Media Injectors Market Size, and Share

*Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

The tiers of the companies are defined based on their total revenue. As of 2023: Tier 1 => USD 1 billion, Tier 2 = USD 200-500 million to USD 1 billion, and Tier 3 =< USD 200 million

To know about the assumptions considered for the study, download the pdf brochure

Market Estimation Methodology

In this report, the contrast media injectors market’s size was determined using the revenue share analysis of leading players. For this purpose, key players in the market were identified, and their revenues from the market business were determined through various insights gathered during the primary and secondary research phases. Secondary research included the study of the annual and financial reports of the top market players. In contrast, primary research included extensive interviews with key opinion leaders, such as CEOs, directors, and key marketing executives.

Segmental revenues were calculated based on the revenue mapping of major solution providers to calculate the global market value. This process involved the following steps:

  • Generating a list of major global players operating in the contrast media injectors market.
  • Mapping annual revenues generated by major global players from the product segment (or nearest reported business unit/product category)
  • Revenue mapping of major players to cover a major share of the global market share, as of 2023
  • Extrapolating the global value of the contrast media injectors market industry

Bottom-up approach

In this report, the size of the global contrast media injectors market was determined using the revenue share analysis of leading players. For this purpose, key players in the market were identified, and their revenues from the contrast media injectors business were determined through various insights gathered during the primary and secondary research phases. Secondary research included the study of the annual and financial reports of the top market players. In contrast, primary research included extensive interviews with key opinion leaders, such as CEOs, directors, and marketing executives.

Approach 1: Company revenue estimation approach

To calculate the global market value, segmental revenues were calculated based on the revenue mapping of major solution/product providers. This process involved the following steps:

  • Generating a list of major global players operating in the contrast media injectors market
  • Mapping the annual revenues generated by major global players from the contrast media injectors segment (or the nearest reported business unit/product category)
  • Mapping the revenues of major players to cover at least 80-90% of the global market share as of 2023
  • Extrapolating the global value of the contrast media injectors industry

Market Size Estimation For Contrast Media Injectors: Approach 1 (Company Revenue Estimation)

Contrast Media Injectors Market Size, and Share

To know about the assumptions considered for the study, Request for Free Sample Report

Approach 2: Customer-based market estimation

During preliminary secondary research, the total sales revenue of contrast media injectors was estimated and validated at the regional and country level, triangulated, and validated to estimate the global market value. This process involved the following steps:

  • Generating a list of major customer facilities across each region and country
  • Identifying the average number of contrast media injectors supplies used by major customer facilities across each product type at the regional/country level, annually
  • Identifying the percentage contribution of major customer facilities to the overall contrast media injectors expenditure and usage at the regional/country level, annually
  • Extrapolating the annual usage patterns for various products across major customer facilities to estimate the size of each product segment at the regional/country level, annually
  • Identifying the percentage contributions of individual market segments and subsegments to the overall contrast media injectors market at the regional/country level

Contrast Media Injectors Market Size Estimation: Bottom-Up Approach

Contrast Media Injectors Market Size, and Share

Source: MarketsandMarkets Analysis

Data Triangulation

After arriving at the overall market size from the market size estimation process explained above, the global contrast media injectors market was split into segments and subsegments. Data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments. The data was triangulated by studying various factors and trends from both the demand and supply sides. Additionally, the contrast media injectors market was validated using top-down and bottom-up approaches.

Market Definition

Contrast media injectors are used to administer contrast agents/contrast media into a patient’s body to enable radiologists to get enhanced visualization of body structures & internal organs during medical procedures such as computed tomography (CT), magnetic resonance imaging (MRI), angiography, and Positron Emission Tomography (PET). The contrast media injection systems are majorly used for applications such as radiology, interventional radiology, and interventional cardiology. Major end users in this market are hospitals and diagnostic imaging centers.

Key Stakeholders

  • Contrast media injectors manufacturers
  • Original equipment manufacturers (OEMs)
  • Suppliers, distributors, and channel partners
  • Healthcare service providers
  • Hospitals
  • Interventional radiologists
  • Research laboratories
  • Health insurance providers
  • Government bodies/organizations
  • Regulatory bodies
  • Medical research institutes
  • Business research and consulting service providers
  • Venture capitalists and other public-private funding agencies
  • Market research and consulting firms

Objectives of the Study

  • To define, describe, and forecast the contrast media injectors market based on product, type, application, end user, and region
  • To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and challenges)
  • To strategically analyze micro markets with respect to individual growth trends, prospects, and contributions to the total market
  • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the revenue of the market segments with respect to five regions, namely, North America, Europe, the Asia Pacific, Latin America, Middle East and Africa
  • To profile the key players and comprehensively analyze their market ranking and core competencies
  • To benchmark players within the market using a proprietary competitive leadership mapping framework, which analyzes market players on various parameters within the broad categories of  market share and product footprint

Available Customizations

With the given market data, MarketsandMarkets offers customizations per the company’s specific needs. The following customization options are available for the present global contrast media injectors market report:

Product Analysis

  • Product matrix, which gives a detailed comparison of the product portfolios of the top five companies

Company Information

  • Detailed analysis and profiling of additional market players (up to five)

Geographic Analysis

  • Further breakdown of the Rest of Europe contrast media injectors market into Russia, Belgium, the Netherlands, Switzerland, Austria, Finland, Sweden, Poland, and Portugal, among others
  • Further breakdown of the Rest of Asia Pacific contrast media injectors market into Singapore, Taiwan, New Zealand, Philippines, Malaysia, and other APAC countries
  • Further breakdown of the Rest of Latin America (RoLATAM), which comprises Argentina, Chile, Peru, Colombia, and Cuba
Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Request Customization

Instant Answers with GPT - Ask Now!

Ask real questions. Get complete answers !
Report Code
MD 5244
Published ON
Jul, 2024
REQUEST FREE SAMPLE REPORT
Choose License Type
BUY NOW
Inquire Before Buying
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Contrast Media Injectors Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2024 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status Website Feedback